The short/bashers prob hit report video 20x a minute all through the night to try get video removed. Focus is on now international sales -the world stage now - US FDA may not care about lives since they “have it under control” (only 500,000 deaths or so) but other countries will be happy to purchase leronlimab based off the data we have now. After a couple
Month additional trial we won’t have enough supply to feed the demand. I think long haulers will be more successful than severe critical because they have learned a lot of about endpoints and Pvalue from the last year. Also learned to in jest in the world not just the US FDA.